Neurological Care and the COVID-19 Pandemic
Offers a thorough discussion of the impact the virus has had on the care of patients with neurological ailments, accompanied by recommendations on how to care for these patients.
Covers the impact of COVID-19 on patients with cerebrovascular diseases, seizures, demyelinating diseases, neuromuscular disorders, movement disorders, headache disorders, cognitive disorders, and neuro-oncological disorders.
Includes a detailed case study of how one healthcare system hit hard by COVID-19 successfully transformed itself to respond to the challenges imposed by the pandemic.
Consolidates today's available information on this timely topic into a single, convenient resource.
|Author Information||Edited by Ahmad Riad Ramadan, MD, Neurologist, Stroke and Neurocritical Care, Henry Ford Neuroscience Institute, Henry Ford Hospital, Detroit, Michigan and Gamaleldin Osman, MD, Epilepsy fellow at Mayo Clinic Hospital and Assistant Professor at Mayo School of Medicine, Rochester, MN, United States|
|Table of Content||1. Fears and hopes
2. Neuropathogenesis of SARS-CoV-2 infection
3. Neurological presentations of COVID-19
4. COVID-19 and cerebrovascular diseases
5. COVID-19 and seizures
6. COVID-19 and autoimmune demyelinating diseases
7. COVID-19 and neuromuscular disorders
8. Pediatric neurology and the COVID-19 pandemic
9. Neuro-oncologic care during the COVID-19 pandemic
10. COVID-19 infection: Impaired olfaction, movement disorders, encephalopathy, and neuropsychiatric manifestations
11. COVID-19 and headache disorders
12. Treatment approach, pharmacological agents and vaccines
13. Response of healthcare systems to the pandemic
|trim||235 x 191 (7 1/2 x 9 1/4)|